Influence of long-term oxygen therapy on cardiac acceleration and deceleration capacity in hypoxic patients with chronic obstructive pulmonary disease

Clinical Physiology and Functional Imaging

Volumn 31, Issue 4, 2011, Pages 258-265

  Lewis, M J ^a,b   Annandale, J ^b   D'Silva, L A ^a   Davies, R E ^a   Reed, Z ^a   Lewis, K E ^b,c  

^a SWANSEA UNIVERSITY   (United Kingdom)

^b PRINCE PHILIP HOSPITAL   (United Kingdom)

^c SWANSEA UNIVERSITY   (United Kingdom)

Author keywords

Chronic obstructive pulmonary disease; ECG; Heart rate; Heart rate turbulence; Oxygen therapy; Phase rectified signal averaging

Indexed keywords

CARBON DIOXIDE; OXYGEN;

AGED; ARTICLE; CARBON DIOXIDE TENSION; CARDIAC ACCELERATION CAPACITY; CARDIAC DECELERATION CAPACITY; CARDIOVASCULAR PARAMETERS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIRCADIAN RHYTHM; CLINICAL ARTICLE; CONTROLLED STUDY; ELECTROCARDIOGRAPHY MONITORING; ENERGY EXPENDITURE; FEMALE; HEART RATE; HEART RATE TURBULENCE; HUMAN; HYPOXIA; MALE; OXYGEN TENSION; OXYGEN THERAPY; PHYSICAL ACTIVITY; PRIORITY JOURNAL; THERAPY EFFECT;

ACCELERATION; ADULT; AGED; AGED, 80 AND OVER; ANOXIA; FEMALE; HEART; HEART RATE; HUMANS; MALE; OXYGEN INHALATION THERAPY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 79958780808     PISSN: 14750961     EISSN: 1475097X     Source Type: Journal    
DOI: 10.1111/j.1475-097X.2011.01010.x     Document Type: Article

References (30)

1. Bartels M, Gonzalez J, Kim W, Meersman R. Oxygen supplementation and cardiac-autonomic modulation in COPD. Chest (2000); 118: 691-696.
2. Bartels M, Jelic S, Ngai P, Basner RC, DeMeersman RE. High frequency modulation of heart rate variability during exercise in patients with COPD. Chest (2003); 124: 863-869.
3. Barthel P, Schneider R, Bauer A, Ulm K, Schmitt C, Schömig A, Schmidt G. Risk stratification after acute myocardial infarction by heart rate turbulence. Circulation (2003); 108: 1221-1226.
4. Bauer A, Kantelhardt JW, Barthel P, Schneider R, Mäkikallio T, Ulm K, Hnatkova K, Schömig A, Huikuri H, Bunde A. Deceleration capacity of heart rate as a predictor of mortality after myocardial infarction: cohort study. Lancet (2006); 367: 1674-1681.
5. Bauer A, Malik M, Schmidt G, Barthel P, Bonnemeier H, Cygankiewicz I, Guzik P, Lombardi F, Mueller A, Oto A, Schneider R, Watanabe M, Wichterle D, Zareba W. Heart rate turbulence: standards of measurement, physiological interpretation, and clinical use: international society for holter and noninvasive electrophysiology consensus. J Am Coll Cardiol (2008); 52: 1353-1365.
6. Billman GE, Schwartz PJ, Stone HL. Baroreceptor reflex control of heart rate: a predictor of sudden cardiac death. Circulation (1982); 66: 874-880.
7. British Thoracic Society. Managing stable COPD. Thorax (2004); 59: i39-i130. Available at
8. Buist AS, McBurnie MA, Vollmer WM, Gillespie S, Burney P, Mannino DM, Menezes AM, Sullivan SD, Lee TA, Weiss KB, Jensen RL, Marks GB, Gulsvik A, Nizankowska-Mogilnicka E; BOLD Collaborative Research Group. International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet (2007); 370: 741-750.
9. Donaldson GC, Hurst JR, Smith CJ, Hubbard RB, Wedzicha JA. Increased risk of myocardial infarction and stroke following exacerbation of chronic obstructive pulmonary disease. Chest (2010); 137: 1091-1097.
10. Eckberg DL, Drabinsky M, Braunwald E. Defective cardiac parasympathetic control in patients with heart disease. N Engl J Med (1971); 285: 877-883.
11. Finkelstein J, Cha E, Scharf SM. Chronic obstructive pulmonary disease as an independent risk factor for cardiovascular morbidity. Int J Chron Obstruct Pulmon Dis. (2009); 4: 337-349.
12. Ghuran A, Reid F, La Rovere MT, Schmidt G, Bigger JT Jr, Camm AJ, Schwartz PJ, Malik M. Heart rate turbulence-based predictors of fatal and nonfatal cardiac arrest (The Autonomic Tone and Reflexes After Myocardial Infarction substudy). Am J Cardiol (2002); 89: 184-190.
13. Gunduz H, Talay F, Arinc H, Ozyildirim S, Akdemir R, Yolcu M, Kanat M, Uyan C. Heart rate variability and heart rate turbulence in patients with chronic obstructive pulmonary disease. Cardiol J (2009); 16: 553-559.
14. Hjalmarsen A, Aasebø U, Aleksandersen G, Jorde R. Cardiovascular responses to tests for autonomic dysfunction in patients with chronic obstructive pulmonary disease with and without continuous long-term oxygen therapy. J Auton Nerv Syst (1996); 60: 169-174.
15. Lewis MJ, Annandale J, Lewis KE. Influence of long-term oxygen therapy on heart rate and QT time series in hypoxic patients with chronic obstructive pulmonary disease. Clin Physiol Funct Imaging (2009); 29: 431-439.
16. Lin LY, Lai LP, Lin JL, Du CC, Shau WY, Chan HL, Tseng YZ, Huang SK. Tight mechanism correlation between heart rate turbulence and baroreflex sensitivity: sequential autonomic blockade analysis. J Cardiovasc Electrophysiol (2002); 13: 427-431.
17. Malerba M, Romanelli G. Early cardiovascular involvement in chronic obstructive pulmonary disease. Monaldi Arch Chest Dis (2009); 71: 59-65.
18. Marine JE, Watanabe MA, Smith TW, Monahan KM. Effect of atropine on heart rate turbulence. Am J Cardiol (2002); 89: 767-769.
19. Medical Research Council Working Group. Long-term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis emphysema. Lancet (1981); 1: 681-686.
20. Nocturnal Oxygen Therapy Trial Group. Continuous or nocturnal oxygen therapy in hypoxaemic chronic obstructive lung disease. A clinical trail.. Ann Intern Med (1980); 93: 391-398.
21. Pagani M, Lucini D, Pizzinelli P, Sergi M, Bosisio E, Mela GS, Malliani A. Effects of aging and of chronic obstructive pulmonary disease on RR interval variability. J Auton Nerv Syst (1996); 59: 125-132.
22. Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P, Fukuchi Y, Jenkins C, Rodriguez-Roisin R, van Weel C, Zielinski J. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med (2007); 176: 532-555.
23. Scalvini S, Porta R, Zanelli E, Volterrani M, Vitacca M, Pagani M, Giordano A, Ambrosino N. Effects of oxygen on autonomic nervous system dysfunction in patients with chronic obstructive pulmonary disease. Eur Respir J (1999); 13: 119-124.
24. Schmidt G, Malik M, Barthel P, Schneider R, Ulm K, Rolnitzky L, Camm AJ, Bigger JT Jr, Schömig A. Heart-rate turbulence after ventricular premature beats as a predictor of mortality after acute myocardial infarction. Lancet (1999); 353: 1390-1396.
25. Schwartz PJ, La Rovere MT, Vanoli E. Autonomic nervous system and sudden cardiac death: experimental basis and clinical observations for post-myocardial infarction risk stratification. Circulation (1992); 85(Suppl. 1): I77-I91.
26. Selcuk H, Maden O, Selcuk MT, Celenk MK, Geyik B, Tüfekcioglu O. Documentation of impaired coronary blood flow in chronic obstructive pulmonary disease patients. Circ J (2010); 74: 346-352.
27. Singh S, Loke YK, Furberg CD. Inhaled anticholinergics and risk of major adverse cardiovascular events in patients with chronic obstructive pulmonary disease. JAMA (2008); 300: 1439-1450.
28. Stewart AG, Waterhouse JC, Howard P. Cardiovascular autonomic nerve function in patients with hypoxaemic chronic obstructive pulmonary disease. Eur Respir J (1991); 4: 1207-1214.
29. Tashkin DP, Celli B, Senn S, Burkhart D, Kesten S, Menjoge S, Decramer M; for the UPLIFT Study Investigators. A 4-year trial of tiotropium in chronic obstructive pulmonary disease. N Engl J Med (2008); 359(Suppl. 15): 1543-1554.
30. Volterrani M, Scalvini S, Mazzuero G, Lanfranchi P, Colombo R, Clark AL, Levi G. Decreased heart rate variability in patients with chronic obstructive pulmonary disease. Chest (1994); 106: 1432-1437.